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ABSTRACT 
Objective: The objective of the study was to develop floating in situ gel formulations of Ciprofloxacin that has a narrow absorption window and 
mainly absorbed in the proximal areas of GIT. These formulations increases the targeted action on bacteria for a longer time that can be used in the 
treatment of Helicobacter pylori (H. pylori) infections and urinary tract infections. 
Methods: In situ gel formulations were prepared by varying concentrations of sodium alginate as in situ gel forming bio-degradable polymer and 
calcium carbonate as a cross-linking agent. The formulations were evaluated for Physical appearance, pH, in vitro drug release, viscosity, in vitro 
floating behaviour, in vitro gelling capacity and drug content. FTIR was conducted for Ciprofloxacin, excipients used and optimized formulation.  
Results: All the formulations showed an optimum viscosity that will allow ease of administration and swallowing. Floating lag time of all formulations 
was between 32-70 seconds and floated for>12 h. The in vitro gelling capacity increased with increasing the polymer and gelling agent concentrations. 
Increase in polymer concentration decreased the rate and extent of the drug release. Among all the formulations, F4 containing 4% w/v of sodium 
alginate and 4% w/v of calcium carbonate showed sustained in vitro drug release (95.6%) over an extended period of 12 h. FTIR studies revealed no 
interaction between drug and excipients used. Drug release from the formulations followed First order kinetics with Fickian diffusion. 
Conclusion: Ciprofloxacin was successfully formulated as a pH-triggered floating in situ
Keywords: In situ gel, Sodium alginate, Calcium carbonate, Ciprofloxacin 
 gelling system using sodium alginate.  




Oral administration is the most convenient and preferred means of 
drug delivery to the systemic circulation. Oral controlled release 
drug delivery has recently been of increasing interest to achieve 
improved therapeutic advantages, such as ease of administration, 
patient compliance, and flexibility in formulation. In situ gel-forming 
polymeric formulations is in sol form before administration undergo 
gelation in situ to form a gel [1]. These in situ solutions are liquid at 
room temperature but undergo gelation when in contact with body 
fluids or change in pH. These have a characteristic property of 
temperature dependent, pH-dependent and cation induced gelation. 
Compared to conventional controlled release formulations, in situ 
forming drug delivery systems possess potential advantages like 
simple manufacturing process, ease of administration, reduced fre-
quency of administration, and improved patient compliance and 
comfort [2-4]. Floating in situ gel drug delivery systems have been 
used to deliver many drugs which are used either for their systemic 
or for their local effects in the stomach [5]. A major constraint in the 
oral controlled drug delivery is that not all drug candidates are 
absorbed uniformly throughout the gastrointestinal tract (GIT), and 
some drugs are absorbed only in a particular portion of GIT or 
absorbed to a different extent in various segments of the GIT. The 
pH-dependent solubility and stability levels of a drug play an 
important role in its absorption. In the case of the drug Ciprofloxacin 
HCl (CPF HCl), it has a narrow absorption window and mainly 
absorbed in the proximal areas of GIT [6]. Therefore, the researchers 
were developed certain gastro retentive systems of CPF HCl such as 
floating systems [7, 8]. Ciprofloxacin belongs to the family of 
quinolones (the term refers to potent chemotherapeutic 
antibacterial agents) [9]. Ciprofloxacin is a broad-spectrum 
antibiotic active against both Gram-positive and Gram-negative 
bacteria. It functions by inhibiting DNA gyrase, a Type II 
topoisomerase and topoisomerase IV, enzymes necessary to 
separate bacterial DNA, thereby inhibiting cell division and also 
affect mammalian cell replication [10].
MATERIALS AND METHODS 
 The objective of the present 
study was to develop ciprofloxacin floating in situ gel that remains in 
the stomach, resulting in increased gastric residence time and thus 
increases the local concentration of the drug for complete 
eradication of H. pylori [5]. The present investigation deals with the 
formulation, optimization, and evaluation of Sodium alginate, HPMC 
K100M based floating oral in situ gel of CPF HCl in which calcium 
carbonate, sodium alginate were used as a cross-linking agent. The 
gel was evaluated for parameters like floating lag time, floating 
duration, gel strength, density, viscosity, pH, in vitro drug release, 
drug content, and in vitro gelling capacity. 
Materials 
Ciprofloxacin HCl (Gift sample procured from Dr. Reddy's 
Laboratories, India), sodium alginate and Hydroxyl propyl methyl 
cellulose (HPMC K100M) (Yarrow Chem, India), sodium citrate, 
methylparaben and propylparaben (Himedia Laboratories, India). 
All other reagents were of analytical grade. 
Methods 
Preparation of floating in situ gels of ciprofloxacin 
Sodium alginate form pH-triggered in situ gel in the presence of 
calcium ions as a cross-linking agent in the gastric fluid. Sodium 
alginate solutions of different concentrations were prepared by 
dissolving the specified amount of sodium alginate in 100 ml of 
distilled water. The appropriate amount of sodium alginate, 0.4% w/v 
of HPMCK100M and 0.5% w/v of sodium citrate were dissolved in 
sufficient amount of distilled water and stirred for 20 min on the 
mechanical stirrer (M/s. Remi, Model: RQ-124 A/D) for complete 
swelling of polymers. Drug solution containing 500 mg of the drug in 
17 ml of 0.1N HCl was slowly added to 20 ml of polymer solution with 
continuous stirring on the mechanical stirrer for 15 min. Specified 
concentrations of CaCO3 were prepared in distilled water and add to 
the polymer solution while stirring, continue stirring for 10 min. For 
the final preparation directly add 0.09% w/v of methylparaben, 0.09% 
w/v of propylparaben and continue stirring for 2 min. Finally, make up 
the volume to 50 ml with distilled water. A composition of different 
formulations of ciprofloxacin were shown in table 1. 
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Table 1: In situgel compositions of different formulations of ciprofloxacin 
Ingredients (mg) F1 F2 F3 F4 F5 F6 F7 F8 
Ciprofloxacin 500 500 500 500 500 500 500 500 
HPMC K100M 200 200 200 200 200 200 200 200 
Sodium alginate 500 1000 1500 2000 500 1000 1500 2000 
Calcium carbonate 500 1000 1500 2000 250 500 750 1000 
Sodium citrate 250 250 250 250 250 250 250 250 
Methylparaben 45 45 45 45 45 45 45 45 
Propylparaben 45 45 45 45 45 45 45 45 
Distilled water up to (ml) 50 50 50 50 50 50 50 50 
 
Evaluation 
Fourier Transform Infrared (FTIR) compatibility studies 
Compatibility studies of drug and the polymer were carried out by 
using fourier transform infrared spectroscopy (FTIR). Fourier 
transform infrared spectra of the samples were obtained in the 
range of 4000 to 450 cm-1
Determination of drug content 
Accurately, 10 ml of the formulation (containing the equivalent of 30 
mg CPF HCl) from completely different batches was measured and 
transferred to a 100 ml volumetric flask. To the current 50-70 ml of 
0.1N, HCl was sonicated for 30 min. Volume was adjusted to a 100 
ml. Complete dispersion of the contents was ensured visually, and 
therefore the dispersion was filtered through Whatman's paper. 
From this answer, 10 ml of the sample was withdrawn and diluted to 
a 100 ml with 0.1N HCl. The contents of the compound were 
measured at most absorbance at 237 nm using double beam UV 
Visible Spectrophotometer (M/s. Elico, Model: SL210) [12]. 
pH measurement  
The pH of the prepared formulations was measured using a 
calibrated digital pH meter (M/s. Elico, Model: LI120) [13]. 
The viscosity of in-situ gelling solutions 
A viscosity of the all the prepared in situ gel formulations are 
studied by using Brookfield Viscometer. 
In vitro gelation study  
To evaluate in vitro gelling capability, accurately measured 10 ml of 
formulation was added to a 100 ml of 0.1N HCl at 37 ° C in a beaker 
with gentle agitation that avoids breaking of farmed gel. The in vitro 
gelling capability was categorized into 3 classes on the idea of the 
stiffness of farmed gel, gelation time and period that the gel remains 
intrinsically [14].  
(+) Gels after few minutes dispersed rapidly  
 using an FTIR (M/s Shimadzu, Model: IR 
Spirit) by the KBr disc method [11]. 
(++) Gelation immediate remains for few hours  
(+++) Gelation immediate remains for an extended period 
In vitro floating study 
The in vitro floating study was administered by introducing 10 ml of 
the formulation into a beaker containing 900 ml of 0.1N HCl (pH 1.2) 
at 37˚C without much disturbance. The time the formulation took to 
emerge on the medium surface (floating lag time) and also the time 
the formulation perpetually floated on the surface of the dissolution 
medium (Duration of floating) were recorded [15, 16]. 
In vitro drug release study 
The dissolution studies were performed using type USP II (paddle 
method) dissolution apparatus (M/s. Labindia, Model: DS 8000). The 
dissolution medium used was 900 ml of 0.1N HCl maintained at 37 ° 
C. The stirring rate was adjusted to 50 rpm. This speed was believed 
to stimulate the in vivo existing delicate agitation and was slow 
enough to avoid the breaking of the gelled formulation. At the 
predetermined time intervals, 1 ml samples were withdrawn and 
replaced by fresh dissolution medium, filtered through Whatman's 
paper, diluted and assayed at 237 nm using double beam UV Visible 
Spectrophotometer [17, 18]. 
RESULTS AND DISCUSSION 
FTIR interpretation studies 
Spectra’s of drug and drug, polymer mixtures were given in fig. 1,2,3 and 
4. No interaction was observed between drug and polymer. In FTIR 
spectra of ciprofloxacin, one prominent characteristic peak was found 
between 3500 and 3450 cm-1, which was assigned to stretching 
vibration of OH groups and intermolecular hydrogen bonding. Another 
band at 3000-2950 cm-1 represented alkene and aromatic C-H 
stretching, mainly C-H. 1950 to 1450 cm-1 region exhibited FTIR 
absorption from a wide variety of double-bonded functional groups. The 
band at 1750 to 1700 cm-1 represented the carbonyl C=O stretching, i.e., 
C=O. The peak between 1650 and 1600 cm-1 was assigned to quinolones. 
The band from 1450 to 1400 cm-1 represented C=O and at 1300 to 1250 
cm-1 suggested bending vibration of the O-H group which proved the 
presence of carboxylic acid. A strong absorption peak between 1050 and 
1000 cm-1
 
 was assigned to a C-F group. From FTIR studies, it is clear that 
there is no interaction between drug and polymers. 
 
Fig. 1: FTIR spectra of ciprofloxacin 
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Fig. 2: FTIR spectra of sodium alginate 
 
 
Fig. 3: FTIR spectra of HPMC K100M 
 
 
Fig. 4: FTIR spectra of the formulation 
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Physical appearance and pH 
The measurement of pH is very important for oral preparations, 
otherwise, it leads to irritation to the throat. All the formulations had 
a slightly acidic pH. The pH of formulations was found in the range of 
5.80-5.93 as shown in table 2. 
The viscosity of in situ gelling solutions 
The formulation should have an optimum viscosity that will allow 
ease of administration and swallowing as a liquid and produce 
satisfactory gel strength for use as a delivery vehicle. Results of 
viscosity for formulations F1 to F8 are shown in table 2. The 
formulations showed an increase in viscosity with increasing the 
concentration of gel forming polymer sodium alginate as a 
consequence of the increase in chain interaction. The concentration 
of sodium alginate (2000 mg and 1500 mg) was found to produce a 
satisfactory viscosity increase which provides sustained release of 
the drug. Calcium carbonate also contributes to increasing the 
viscosity of the formulations. The viscosity of formulation increased 
with an increase in sodium alginate and calcium carbonate 
concentration. As calcium carbonate increases cross-linking 
tendency of sodium alginate, increase in calcium carbonate 
concentration also increases viscosity. The viscosity of formulations 
was in between 140-390 centipoise. 
In vitro floating behaviour 
The time is taken by the formulation to emerge on the surface of the 
medium (floating lag time) and the time for which the formulation 
constantly floated on the dissolution medium surface (duration of 
floating) is shown in (table 2). In contact with the gastric 
environment, calcium carbonate effervesced, releasing carbon 
dioxide and calcium ions. Then, gelation and complexation by Ca+2 
ions took place to provide a gel barrier at the surface of the 
formulation. The released carbon dioxide was entrapped in the gel 
network producing a buoyant preparation, which resulted in 
extended floating. The floating properties of the formulation, mainly 
depend on calcium carbonate, on increasing the calcium carbonate 
concentration, the floating lag time was reduced, and the duration of 
floating was extended [21]. The increasing amounts of Ca+2 and CO2
Floating lag time and floating time were shown in table 2. The 
floating lag time is minimum for F1 and highest to F8. This is 
because F4 and F8 contain the highest concentration of calcium 
carbonate. Increase in polymer concentration results in an increase 
in viscosity. Hence time taken from the sol to form a cohesive gel 
mass and to emerge on the surface of the medium was lowered. The 
in vitro floating test revealed the ability of all formulations to 
maintain buoyancy for more than 12 h. All formulations exhibited 
total floating time of>12 h. Floating lag time varied with formulation 
variables. Floating lag time of all formulations were in between 32-
70 s.  
 
Gel strength resulted from the increase in calcium carbonate 
concentration, are responsible for the observed reduction in floating 
lag time and increasing duration of floating. 
In vitro gelling capacity 
Gelling studies were carried out using 0.1N HCl (pH 1.2), and the 
obtained data were represented in table 2. Gelation occurs when the 
insoluble calcium carbonate solubilize when it comes in contact with 
acidic medium releasing carbon dioxide and calcium ions. The 
calcium ions interact with the anionic polymer (sodium alginate) in 
the formulation causing instantaneous gelation and provide a gel 
barrier that restricts drug release [20]. As the concentration of the 
polymer and calcium carbonate increases the in vitro gelling 
capacity also increases. F1 and F5 formulations had somewhat less 
stiff gels when compared to other formulations. 
Drug content 
The percentage of drug content for all formulations was determined 
and shown in table 2. The drug content was found to be in the range 
of 96.5-98.5% for all the formulations indicating a uniform 
distribution of the drug. 
 
Table 2: Evaluation parameters of in situ gel formulations of ciprofloxacin 
Batch pH Viscosity (centipoise) Floating lag time(s) Total floating time(h) Gelling capacity Drug content (%) 
F1 5.83 180 35±2 >12 ++ 98.2±1.1 
F2 5.93 250 38±1 >12 +++ 97.4±1.3 
F3 5.80 310 45±2 >12 +++ 96.5±1.2 
F4 5.86 390 61±2 >12 +++ 97.5±1.3 
F5 5.83 140 37±3 >12 ++ 98.5±1.1 
F6 5.80 210 43±2 >12 +++ 97.9±1.0 
F7 5.83 270 52±3 >12 +++ 96.8±1.5 
F8 5.82 315 70±2 >12 +++ 97.7±1.6 
 (n = 3, mean±SD) 
 
Table 3: Dissolution data of ciprofloxacin in situ gel formulations 
Time (h) % Cumulative drug released (n = 3, mean±SD) 
F1 F2 F3 F4 F5 F6 F7 F8 M 
0.5 55.6±1.2 50.4±1.3 43.7±1.7 38.5±1.9 60.2±1.6 54.6±1.9 46.8±1.4 41.2±1.5 38.5±1.3 
1 60.8±1.7 54.2±1.5 49.2±1.2 42.7±1.6 67.3±1.4 57.6±1.4 50.6±1.2 45.5±1.2 64.2±1.4 
2 69.6±1.5 59.6±2.0 54.9±1.5 49.5±1.7 74.6±1.3 65.7±1.3 58.7±1.5 51.2±1.5 82.5±1.5 
3 77.8±2.4 66.7±2.1 59.3±1.4 53.8±1.4 85.4±1.2 72.8±1.5 64.4±1.8 58.8±1.7 99.9±1.1 
4 86.2±1.2 70.4±2.3 64.9±1.7 57.6±1.5 94.7±1.7 79.5±1.7 71.3±1.9 65.3±1.4  
5 96.5±1.6 75.9±1.1 70.5±1.8 62.8±1.6 99.5±1.7 84.6±1.8 76.5±1.2 72.3±1.5  
6  83.5±1.4 74.4±1.7 68.4±1.2  90.3±1.2 82.7±1.5 77.5±1.6  
7  89.2±1.2 78.3±1.9 73.9±1.9  98.5±1.1 87.5±1.7 83.8±1.9  
8  97.2±1.5 83.9±1.7 77.3±1.6   93.7±1.6 88.6±1.7  
9  99.3±1.7 89.5±2.3 81.5±2.3   99.8±1.2 92.6±1.5  
10   95.1±1.2 86.6±2.2    98.9±1.3  
11   99.5±1.3 91.7±1.2      
12    95.4±1.2      
 
In vitro drug release 
The in vitro drug release study of ciprofloxacin from all formulations 
was carried out by USP type II dissolution apparatus containing 900 
ml of 0.1N HCl at 37±0.5⁰ C at 50 rpm for 12 h, and the result was 
shown in fig. 6. Dissolution data is represented in table 3. A 
significant decrease in the rate and extent of the drug release was 
observed with the increase in polymer concentration in in situ 
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gelling preparation. The sodium alginate and HPMC with a primary 
role in the sol-gel phenomenon and buoyant also affected the release 
rate to some extent. F1, F2 and F3 released 96.5%, 99.3% and 99.5% 
in 5, 9 and 11 h of dissolution. Formulations F4 to F6 released 
95.4%, 99.5% and 98.5% in 12, 5 and 7 h of dissolution. 
Formulations F7, F8 released 99.8%, 99.9% in 9 and 10 h of 
dissolution respectively. Commercially available product (M), 
CIFRAN showed 99.9% drug release in 4 h. 
Kinetics of drug release 
The cumulative amount of drug released from the systems at 
different time intervals was fitted to different kinetic models of zero 
order, first order, Higuchi model, Korsmeyer-Peppas model, and 
Hixson-Crowell model to find out the mechanism of drug release. 
The in vitro release profile was fitted to various kinetic models in 
order to find out the mechanism of drug release. The goodness of fit 
was evaluated using the correlation coefficient (r2) values. The 
correlation coefficient (r2) for all the formulations using different 
kinetics equation is listed in table 4. The values of r2
 
 for all 
formulations were found higher for the first order model. It was 
found that all formulations mostly followed the first order models as 
the best fit model because of the higher value of r (correlation 
coefficient). The release profile of in situ gelling formulations was 
treated with Korsmeyer-Peppas equation, and slope value n≤0.45 
were indicating fickian diffusion [19]. Kinetic profiles of various 
formulations were shown in fig. 5,6,7 and 8.  
Table 4: Different kinetic models applied on in situ gel formulations 
B atch Zero-order plot First order plot Higuchi plot Korsmeyer Peppas plot Hixson crowell plot 
KR0R (mg. mlP-1 PhP-1 P) r P2 KR1 R(hP-1 P) r P2 r P2 n r P2 
F1 14.35 0.85 0.54 0.95 0.9539 0.23 0.9518 
F2 7.99 0.88 0.42 0.91 0.9644 0.25 0.9602 
F3 6.62 0.92 0.33 0.88 0.9747 0.25 0.9565 
F4 5.53 0.91 0.16 0.98 0.9813 0.28 0.9813 
F5 15.40 0.83 0.65 0.90 0.9608 0.25 0.9554 
F6 8.67 0.87 0.38 0.93 0.9513 0.23 0.9396 
F7 6.89 0.89 0.31 0.88 0.9685 0.32 0.9439 
F8 6.16 0.93 0.26 0.94 0.9798 0.29 0.9766 
M 24.40 0.98 1.97 0.81 0.9920 0.69 0.9482 
 
 
Fig. 5: Comparison of dissolution profiles of ciprofloxacin in situ gel formulations with CIFRAN 
 
 
Fig. 6: First order plots of various formulations and marketed product 
Pashikanti et al. 




Fig. 7: Higuchi plots of various formulations and marketed product 
 
 
Fig. 8: Korsmeyer-peppas plot 
 
CONCLUSION 
The prepared formulations met al. l pre-requisites to become an in 
situ floating system, gelled and floated instantaneously in stomach 
pH. The high concentration of calcium carbonate increased cross-
linking of sodium alginate and form egg case like structures, more 
the cross-linking density less the penetration of water into the 
matrix and limited amount of drug that enters into dissolution fluid. 
Thereby the high concentration of sodium alginate along with HPMC 
K100M (increases strength of the gel) and calcium carbonate had 
sustained effect. Ciprofloxacin was successfully formulated at a pH-
triggered floating in situ gelling system using sodium alginate. The F4 
formulation containing 4% w/v of sodium alginate, 0.4% w/v of HPMC 
K100M and 4% w/v of calcium carbonate shows more sustained in 
vitro release (95.7%) than other formulations over an extended period 
of 12 h. The drug release from a gel structure follows a first-order type, 
and release pattern was fickian diffusion type.  
ACKNOWLEDGMENT 
I express my heartfelt gratitude to the A. U. College of 
Pharmaceutical Sciences, Andhra University for encouragement 
during the course of work. 
AUTHORS CONTRIBUTIONS 
All the author have contributed equally 
CONFLICT OF INTERESTS  
Declared none 
REFERENCES 
1. Chandra, Mohan SB, Manjunatha N, Patel K, Samanta MK, 
Bhaskaran S, et al. Design and development of oral sustained in 
situ gelling systems of famotidine. Indian J Novel Drug Delivery 
2009;1:42-6.  
2. Miyazaki S, Endo K, Kawasaki N, Kubo W, Watanabe H, Attwood 
D, et al. Oral sustained delivery of paracetamol from in situ 
gelling xyloglucan formulations. Drug Dev Ind Pharm 
2003;29:113-9.  
3. Peppas N, Langer R. New challenges in biomaterials. Science 
1994;263:15-20.  
4. Rajinikanth S, Mishra B. Floating in situ gelling systems of 
acetohydroxamic acid for clearance of H. pylori. J Drug Dev Ind 
Pharm 2008;34:577-87.  
5. Lena MT. Formulation and evaluation of floating oral in-situ gel 
of metronidazole. Int J Pharm Pharm Sci 2014;6:265-9. 
6. Naik SB, Venkateswarlu K, Chandrasekhar KB. Formulation and 
in vitro evaluation of orodispersible tablets of olanzapine for 
the improvement of dissolution rate. J Chem Pharm Res 
2016;8:177-81. 
7. Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro 
characterization of ciprofloxacin floating and bioadhesive 
extended-release tablets. Drug Delivery 2006;13:277-85. 
8. Rao S, Ratnam BV. Formulation and optimization of sustained 
release tablets of rosuvastatin using HPMC K4M, HPMC K100M, 
and carrageenan. Int J ChemTech Res 2018;11:376-86. 
9. Nelson JM, Chiller TM, Powers JH, Angulo FJ. Fluoroquinolone-
resistant campylobacter species and the withdrawal of 
Pashikanti et al. 
Int J App Pharm, Vol 11, Issue 1, 2019, 198-204 
 
204 
fluoroquinolones from use in poultry. Clin Infect Dis 
2007;44:977-80.  
10. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-
quinolones. Microbiol Mol Biol Rev 1997;61:377-92. 
11. Mulagada S, Baratam SR. Design and evaluation of ondansetron 
fast disintegrating tablets using natural polymers and modified 
starches as super disintegrants for the enhancement of 
dissolution. J Young Pharm 2017;9:519-24. 
12. Maheswaran A, Padmavathy J, Nandhini V, Saravanan D, Angel 
P. Formulation and evaluation of floating oral in situ gel of 
diltiazem hydrochloride. Int J Appl Pharm 2017;9:50-3. 
13. Patel MJ, Patel KR, Patel MR, Patel NM. Strategy for 
development of pH-triggered floating in-situ gel of 
levetiracetam. Am J Pharm Tech Res 2012;2:828-41.  
14. Vipul V, Basu B. Formulation and characterization of the novel 
floating in-situ gelling system for controlled delivery of 
ramipril. Int J Drug Delivery 2013;5:43-55.  
15. Rao BS, Vijayaratna J, Ramarao CT. Optimization of matrix 
tablets containing alfuzosin HCl employing HPMC K4M. Eur J 
Pharm Med Res 2016;3:529-33. 
16. Thomas LM. Formulation and evaluation of floating oral in-situ 
gel of metronidazole. Int J Pharm Pharm Sci 2014;6:265-9. 
17. Patel DM, Patel CN. Formulation and evaluation of floating oral 
in-situ gelling system of amoxicillin. ISRN Pharm 2011;1:1-8. 
18. Baratam SR, V RatnaJ. Formulation and evaluation of floating 
matrix tablets of levofloxacin hemihydrate using hydroxyl-
propyl methylcellulose k4m to treat Helicobacter pylori 
infection. Asian J Pharm Clin Res 2018;11:148-51. 
19. Reddy RK, Srinivas M, Srinivas R. Once-daily sustained-release 
matrix tablets of nicorandil: formulation and in vitro 
evaluation. AAPS PharmSciTech 2003;4:480-8. 
20. Hasan MJ, Kamal BA. Formulation and evaluation of ranitidine 
hydrochloride are floating In situ gel. Int J Pharm Pharm Sci 
2014;6:401-5. 
21. Nayak A, Maji R, Das B. Gastroretentive drug delivery system: a 
review. Asian J Pharm Clin Res 2010;3:1-10. 
 
